These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 15118616)

  • 1. RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers.
    Mutch DG; Powell MA; Mallon MA; Goodfellow PJ
    Am J Obstet Gynecol; 2004 Apr; 190(4):935-42. PubMed ID: 15118616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic and phenotypic progression in endometrial tumorigenesis: determining when defects in DNA mismatch repair and KRAS2 occur.
    Cohn DE; Mutch DG; Herzog TJ; Rader JS; Dintzis SM; Gersell DJ; Todd CR; Goodfellow PJ
    Genes Chromosomes Cancer; 2001 Dec; 32(4):295-301. PubMed ID: 11746970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation.
    Domingo E; Espín E; Armengol M; Oliveira C; Pinto M; Duval A; Brennetot C; Seruca R; Hamelin R; Yamamoto H; Schwartz S
    Genes Chromosomes Cancer; 2004 Feb; 39(2):138-42. PubMed ID: 14695993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma.
    Sommerer F; Vieth M; Markwarth A; Röhrich K; Vomschloss S; May A; Ell C; Stolte M; Hengge UR; Wittekind C; Tannapfel A
    Oncogene; 2004 Jan; 23(2):554-8. PubMed ID: 14724583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability.
    Swisher EM; Peiffer-Schneider S; Mutch DG; Herzog TJ; Rader JS; Elbendary A; Goodfellow PJ
    Cancer; 1999 Jan; 85(1):119-26. PubMed ID: 9921983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a correlation between the BRAF V600E mutation and abnormal DNA mismatch repair in patients with sporadic endometrial cancer.
    Kawaguchi M; Yanokura M; Banno K; Kobayashi Y; Kuwabara Y; Kobayashi M; Nomura H; Hirasawa A; Susumu N; Aoki D
    Int J Oncol; 2009 Jun; 34(6):1541-7. PubMed ID: 19424571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.
    Miyaki M; Iijima T; Yamaguchi T; Kadofuku T; Funata N; Mori T
    Cancer Lett; 2004 Jul; 211(1):105-9. PubMed ID: 15194222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression.
    Feng YZ; Shiozawa T; Miyamoto T; Kashima H; Kurai M; Suzuki A; Konishi I
    Clin Cancer Res; 2005 Sep; 11(17):6133-8. PubMed ID: 16144912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.
    Wang L; Cunningham JM; Winters JL; Guenther JC; French AJ; Boardman LA; Burgart LJ; McDonnell SK; Schaid DJ; Thibodeau SN
    Cancer Res; 2003 Sep; 63(17):5209-12. PubMed ID: 14500346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
    Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT
    Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
    Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
    J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors.
    Lubomierski N; Plotz G; Wormek M; Engels K; Kriener S; Trojan J; Jungling B; Zeuzem S; Raedle J
    Cancer; 2005 Sep; 104(5):952-61. PubMed ID: 16015629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.
    Pappa KI; Choleza M; Markaki S; Giannikaki E; Kyroudi A; Vlachos G; Voulgaris Z; Anagnou NP
    Gynecol Oncol; 2006 Mar; 100(3):596-600. PubMed ID: 16256179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS mutation and microsatellite instability in endometrial adenocarcinomas showing MELF-type myometrial invasion.
    Stewart CJ; Amanuel B; Grieu F; Carrello A; Iacopetta B
    J Clin Pathol; 2010 Jul; 63(7):604-8. PubMed ID: 20591910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.
    Goodfellow PJ; Buttin BM; Herzog TJ; Rader JS; Gibb RK; Swisher E; Look K; Walls KC; Fan MY; Mutch DG
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5908-13. PubMed ID: 12732731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frameshift mutations in the bax gene are not involved in development of ovarian endometrioid carcinoma.
    Cao SN; Chang KH; Luthra R; Liu J
    Mod Pathol; 2003 Oct; 16(10):1048-52. PubMed ID: 14559989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes.
    Rahman M; Nakayama K; Rahman MT; Nakayama N; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Otsuki Y; Nakayama S; Miyazaki K
    Anticancer Res; 2013 Jan; 33(1):113-8. PubMed ID: 23267135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of transforming growth factor beta receptor type II and DNA mismatch repair genes in sporadic endometrial carcinomas with microsatellite instability.
    Ohwada M; Suzuki M; Saga Y; Suzuki T; Ikeda M; Yamada M; Sato I
    Oncol Rep; 2000; 7(4):789-92. PubMed ID: 10854545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.